Product Images Glycopyrrolate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Glycopyrrolate NDC 51662-1484 by Hf Acquisition Co Llc, Dba Healthfirst, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
CLINICAL - CLINICAL PHARMA
SERIALIZED LABELING - SERIALIZED VIAL LABELING
This is a label of a medication containing 4mg/20mL of a drug that should not be used for anything but intramuscular or intravenous administration. The medication comes in a 20 mL multiple dose vial and contains Benzyl Alcohol, and the manufacturer's package insert should be consulted. The distributed company is HF Acquisition Co., LLC located in Mukilteo, WA 98275. NDC 0143-9679-01 is the product code.*
STRUCTURE - STRUCTURE
VIAL LABEL - VIAL LABELING
Beonly Glycopyrrolate Injection, USP, is a medication used in newborns as indicated in the package. The injection has a concentration of 4 mg/ml and is administered through the intramuscular or intravenous route. This injection is preserved with benzyl alcohol, and its pH is adjusted with hydrochloric acid and/or sodium hydroxide when necessary. The usual dosage is available in the package insert. The drug comes in 20ml vials and should be stored at controlled room temperature. The manufacturer is WEST-WARD, located in Eatonton, NJ, USA. Lot and expiration information is available on the package.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.